When karyotype is decisive for myelodysplastic syndromes diagnosis

INTRODUCTION: The myelodysplastic syndromes (MDS) are a group of heterogeneous clonal hematopoietic stem cell disorders that results in peripheral blood (PB) cytopenias and bone marrow (BM) dysplasia. Dysplasia is the hallmark of the disorder, and must exceed the threshold of 10%. Conventional karyo...

Descripción completa

Detalles Bibliográficos
Autores principales: Perazzio, Aline dos Santos Borgo, Chauffaille, Maria de Lourdes L. Ferrari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978531/
https://www.ncbi.nlm.nih.gov/pubmed/31395457
http://dx.doi.org/10.1016/j.htct.2019.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978531/
https://www.ncbi.nlm.nih.gov/pubmed/31395457
http://dx.doi.org/10.1016/j.htct.2019.03.004

Ejemplares similares